DOCSLIB.ORG

Degradation Elastase Fibrosis Lung Are Due to Neutrophil

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Degradation Elastase Fibrosis Lung Are Due to Neutrophil Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation This information is current as of September 29, 2021. Sinéad Weldon, Paul McNally, Noel G. McElvaney, J. Stuart Elborn, Danny F. McAuley, Julien Wartelle, Abderrazzaq Belaaouaj, Rodney L. Levine and Clifford C. Taggart J Immunol 2009; 183:8148-8156; ; doi: 10.4049/jimmunol.0901716 Downloaded from http://www.jimmunol.org/content/183/12/8148 References This article cites 50 articles, 17 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/183/12/8148.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 29, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation1 Sine´ad Weldon,* Paul McNally,† Noel G. McElvaney,† J. Stuart Elborn,* Danny F. McAuley,* Julien Wartelle,‡ Abderrazzaq Belaaouaj,‡ Rodney L. Levine,§ and Clifford C. Taggart2* Secretory leucoprotease inhibitor (SLPI) is a neutrophil serine protease inhibitor constitutively expressed at many mucosal sur- faces, including that of the lung. Originally identified as a serine protease inhibitor, it is now evident that SLPI also has antimi- crobial and anti-inflammatory functions, and therefore plays an important role in host defense. Previous work has shown that some host defense proteins such as SLPI and elafin are susceptible to proteolytic degradation. Consequently, we investigated the status of SLPI in the cystic fibrosis (CF) lung. A major factor that contributes to the high mortality rate among CF patients is Downloaded from Pseudomonas aeruginosa infection. In this study, we report that P. aeruginosa-positive CF bronchoalveolar lavage fluid, which contains lower SLPI levels and higher neutrophil elastase (NE) activity compared with P. aeruginosa-negative samples, was particularly effective at cleaving recombinant human SLPI. Additionally, we found that only NE inhibitors were able to prevent SLPI cleavage, thereby implicating NE in this process. NE in excess was found to cleave recombinant SLPI at two novel sites in ␬ the NH2-terminal region and abrogate its ability to bind LPS and NF- B consensus binding sites but not its ability to inhibit activity of the serine protease cathepsin G. In conclusion, this study provides evidence that SLPI is cleaved and inactivated by NE http://www.jimmunol.org/ present in P. aeruginosa-positive CF lung secretions and that P. aeruginosa infection contributes to inactivation of the host defense screen in the CF lung. The Journal of Immunology, 2009, 183: 8148–8156. ystic fibrosis (CF)3 is an autosomal recessive disease presence of large numbers of neutrophils and ensuing high con- caused by loss of expression/function mutations in the centrations of neutrophil proteases, particularly neutrophil elastase C cystic fibrosis transmembrane conductance regulator (NE), in the airways of CF patients that overwhelm the host’s (CFTR) protein. Lung disease causes 95% of the morbidity and antiprotease screen (1). During the past three decades it has be- mortality in CF patients and is associated with the failure of pul- come clear that a number of proteins involved in defending the by guest on September 29, 2021 monary innate immune functions leading to a vicious cycle of lung against proteases possess multiple, yet seemingly indepen- continual infection, inflammation, and remodeling of lung tissue dent, functions that under normal circumstances serve to protect (1). A major factor that contributes to this mortality rate is infec- the lung from infection and inflammation as well as protease-in- tion with Pseudomonas aeruginosa. Once chronic infection is es- duced degradation. tablished, it is virtually impossible to eradicate and is associated One such protein is human secretory leucoprotease inhibitor with reduced survival (2, 3). Another contributing factor is the (SLPI), a cationic 11.7 kDa serine protease inhibitor constitutively expressed at mucosal surfaces, primarily the upper respiratory tract. SLPI consists of 107 amino acids organized in two whey *Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, Northern Ireland; †Respiratory Re- acidic protein four disulfide core (WFDC) domains, each with four search Division, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, disulfide bridges (4, 5). SLPI is produced by a number of cell ‡ Ireland; Institut National de la Sante´et de la Recherche Me´dicale, Programme Ave- types, including neutrophils, macrophages, and epithelial cells, and nir/EA Inflammation and Immunity of the Respiratory Epithelium, Universite´de Re- ims Champagne-Ardenne, Institut Fe´de´ratif de Recherche 53, Reims, France; and expression can be altered by various stimuli, including LPS (6, 7), §Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National NE (8, 9), and both pro- and anti-inflammatory cytokines (10, 11). Institutes of Health, Bethesda, MD 20892 Overall, the evidence to date suggests that the function of SLPI is Received for publication May 29, 2009. Accepted for publication October 16, 2009. to protect local tissue from the detrimental consequences of in- The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance flammation not only as a result of its well-documented antiprotease with 18 U.S.C. Section 1734 solely to indicate this fact. activities but also via its antimicrobial and anti-inflammatory prop- 1 This study was supported in part by funding from the Northern Ireland Chest Heart erties. SLPI can inhibit a variety of proteases released during in- and Stroke Association (CT 2008 107) and the American Alpha One Foundation. flammation such as elastase, cathepsin G (CatG), trypsin, chymo- 2 Address correspondence and reprint requests to Dr. Clifford C. Taggart, Centre for trypsin, chymase, and tryptase (12). Meanwhile, a number of Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland. studies have found that SLPI displays antimicrobial effects against E-mail: [email protected] pathogens such as Escherichia coli, P. aeruginosa, and Staphylo- 3 Abbreviations used in this paper: CF, cystic fibrosis; AAT, ␣-1-antitrypsin; ACT, coccus aureus, and it also inhibits the growth of fungi such as ␣-1-antichymotrypsin; BALF, bronchoalveolar lavage fluid; CatG, cathepsin G; Aspergillus fumigatus and Candida albicans (13–15). COPD, chronic obstructive pulmonary disease; MeOSuc-AAPM-pNA, N-(ethoxysuc- cinyl)-Alam-Ala-Pro-Met-paranitroanilide; MeOSuc-AAPV-CMK or CMK, N-(me- SLPI also possesses immunomodulatory activity both in vivo thoxysuccinyl)-Ala-Ala-Pro-Val-chloromethyl ketone; MeOSuc-AAPV-pNA, N-(me- and in vitro. Administration of aerosolized SLPI to CF patients thoxysuccinyl)-Ala-Ala-Pro-Val-paranitroanilide; NE, neutrophil elastase; Pr3, proteinase 3; PsϪ, Pseudomonas-negative; Psϩ, Pseudomonas-positive; SLPI, secre- suppressed levels of both NE and IL-8 in the lung (16, 17). In tory leucoprotease inhibitor; WFDC, whey acidic protein four disulfide core. response to LPS, SLPI-deficient mice show increased mortality www.jimmunol.org/cgi/doi/10.4049/jimmunol.0901716 The Journal of Immunology 8149 from endotoxin shock (18). Furthermore, in a mouse model of Table I. Clinical information for patients included in the studya acute lung injury, prior administration of SLPI decreased lung injury and down-regulated NF-␬B activation by preventing deg- Pseudomonas- Pseudomonas- radation of the NF-␬B inhibitor protein I␬B␤ (19, 20). These Negative Positive p Value findings have been confirmed in vitro and mechanisms of action n 15 11 continue to be elucidated. SLPI binds bacterial LPS extracel- Age (years) 7.75 (1.6) 14 (0.9) 0.0047 lularly, thereby down-regulating the uptake of LPS and subse- BMI (kg/m2) 16.7 (0.6) 17 (0.9) 0.7529 quent production of proinflammatory mediators (21–23). How- FEV1 (% predicted) 71.8 (7.8) 52 (8.7) 0.1080 Neutrophils/ml BALF 2.37 (1.5) 9.01 (1.9) 0.0114 ever, as a consequence of the internalization of SLPI into the cytoplasm and nucleus of cells such as monocytes, it appears a Values represent means (SEM). BMI indicates body mass index; FEV1, forced expiratory volume in 1 s. that SLPI also has intracellular sites of action (24). In the cy- toplasm, SLPI inhibited LPS- and lipoteichoic acid-induced NF-␬B activation in human monocytes, by preventing degrada- ␬ ␣ ␬ ␤
Load more

Recommended publications
  • In Vivo Suppression of Immune Complex-Induced Alveolitis by Secretory Leukoproteinase Inhibitor and Tissue Inhibitor of Metalloproteinases 2 MICHAEL S
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11523-11527, December 1993 Medical Sciences In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2 MICHAEL S. MULLIGAN*, PAUL E. DESROCHERSt, ARUL M. CHINNAIYANt, DOUGLAS F. GIBBS*, JAMES VARANI*, KENT J. JOHNSON*, AND STEPHEN J. WEISSt* Departments of *Pathology and tlnternal Medicine, University of Michigan, Ann Arbor, MI 48109 Communicated by Hilary Koprowski, August 12, 1993 ABSTRACT The pulmonary tree is exposed to neutrophil- cellular matrix (4, 5). Because rat and human neutrophil derived serine proteinases and matrix metalloproteinases in proteinases display considerable homology (6), we reasoned inflaMmatory lung diseases, but the degree to which these that the rat model might afford the opportunity to assess the enzymes participate in tissue injury remains undefined, as does role of leukocyte-derived proteolytic enzymes in lung dam- the therapeutic utility of antiproteinase-based interventions. age in vivo and evaluate the therapeutic efficacy of antipro- To address these issues, an in vivo rat model was examined in teinases relevant to human intervention. Herein, we demon- which the intrapulmonary deposition of immune complexes strate that the serine proteinase inhibitor, secretory leuko- initiates a neutrophil-mediated acute alveolitis. In vitro studies proteinase inhibitor (SLPI; refs. 7 and 8), and the matrix demonstrated that rat neutrophils can release neutrophil metalloproteinase inhibitor, tissue inhibitor of metallopro- elastase and cathepsin G as weDl as a neutrophil progelatinase, teinases 2 (TIMP-2; refs. 9 and 10), are able to specifically which was subsequentiy activated by either chlorinated oxi- regulate homologous rat proteinases in vitro and can, when dants or serine proteinases.
    [Show full text]
  • The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection
    The S100A10 Subunit of the Annexin A2 Heterotetramer Facilitates L2-Mediated Human Papillomavirus Infection Andrew W. Woodham1, Diane M. Da Silva2,3, Joseph G. Skeate1, Adam B. Raff1, Mark R. Ambroso4, Heike E. Brand3, J. Mario Isas4, Ralf Langen4, W. Martin Kast1,2,3* 1 Departments of Molecular Microbiology & Immunology, University of Southern California, Los Angeles, California, United States of America, 2 Department of Obstetrics & Gynecology, University of Southern California, Los Angeles, California, United States of America, 3 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, United States of America, 4 Department of Biochemistry & Molecular Biology, University of Southern California, Los Angeles, California, United States of America Abstract Mucosotropic, high-risk human papillomaviruses (HPV) are sexually transmitted viruses that are causally associated with the development of cervical cancer. The most common high-risk genotype, HPV16, is an obligatory intracellular virus that must gain entry into host epithelial cells and deliver its double stranded DNA to the nucleus. HPV capsid proteins play a vital role in these steps. Despite the critical nature of these capsid protein-host cell interactions, the precise cellular components necessary for HPV16 infection of epithelial cells remains unknown. Several neutralizing epitopes have been identified for the HPV16 L2 minor capsid protein that can inhibit infection after initial attachment of the virus to the cell surface, which suggests an L2-specific secondary receptor or cofactor is required for infection, but so far no specific L2-receptor has been identified. Here, we demonstrate that the annexin A2 heterotetramer (A2t) contributes to HPV16 infection and co- immunoprecipitates with HPV16 particles on the surface of epithelial cells in an L2-dependent manner.
    [Show full text]
  • Granulin: an Invasive and Survival-Determining Marker in Colorectal Cancer Patients
    International Journal of Molecular Sciences Article Granulin: An Invasive and Survival-Determining Marker in Colorectal Cancer Patients Fee Klupp 1,*, Christoph Kahlert 2, Clemens Franz 1, Niels Halama 3, Nikolai Schleussner 1, Naita M. Wirsik 4, Arne Warth 5, Thomas Schmidt 1,4 and Alexis B. Ulrich 1,6 1 Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany; [email protected] (C.F.); [email protected] (N.S.); [email protected] (T.S.); [email protected] (A.B.U.) 2 Department of Visceral, Thoracic and Vascular Surgery, University of Dresden, Fetscherstr. 74, 01307 Dresden, Germany; [email protected] 3 National Center for Tumor Diseases, Medical Oncology and Internal Medicine VI, Tissue Imaging and Analysis Center, Bioquant, University of Heidelberg, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany; [email protected] 4 Department of General, Visceral und Tumor Surgery, University Hospital Cologne, Kerpener Straße 62, 50937 Cologne, Germany; [email protected] 5 Institute of Pathology, University of Heidelberg, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany; [email protected] 6 Department of General and Visceral Surgery, Lukas Hospital Neuss, Preußenstr. 84, 41464 Neuss, Germany * Correspondence: [email protected]; Tel.: +49-6221-566-110; Fax: +49-6221-565-506 Abstract: Background: Granulin is a secreted, glycosylated peptide—originated by cleavage from a precursor protein—which is involved in cell growth, tumor invasion and angiogenesis. However, Citation: Klupp, F.; Kahlert, C.; the specific prognostic impact of granulin in human colorectal cancer has only been studied to a Franz, C.; Halama, N.; Schleussner, limited extent.
    [Show full text]
  • The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
    The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung Twigg, M. S., Brockbank, S., Lowry, P., FitzGerald, S. P., Taggart, C., & Weldon, S. (2015). The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung. Mediators of Inflammation, 2015, [293053]. https://doi.org/10.1155/2015/293053 Published in: Mediators of Inflammation Document Version: Publisher's PDF, also known as Version of record Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights Copyright © 2015 The authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:07. Oct. 2021 Hindawi Publishing Corporation Mediators of Inflammation Volume 2015, Article ID 293053, 10 pages http://dx.doi.org/10.1155/2015/293053 Review Article The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung Matthew S.
    [Show full text]
  • Uterine-Associated Serine Protease Inhibitors Stimulate Deoxyribonucleic Acid Synthesis in Porcine Endometrial Glandular Epithelial Cells of Pregnancy 1
    BIOLOGY OF REPRODUCTION 61, 380±387 (1999) Uterine-Associated Serine Protease Inhibitors Stimulate Deoxyribonucleic Acid Synthesis in Porcine Endometrial Glandular Epithelial Cells of Pregnancy 1 Lokenga Badinga, Frank J. Michel, and Rosalia C.M. Simmen2 Animal Molecular and Cell Biology Interdisciplinary Concentration, Department of Animal Science, University of Florida, Gainesville, Florida 32611-0910 ABSTRACT Consistent with this, uteri from mammalian species with distinct placentation types express common classes of pro- Protease inhibitors are major secretory components of the tease inhibitors (e.g., tissue inhibitors of metalloproteases, Downloaded from https://academic.oup.com/biolreprod/article/61/2/380/2734487 by guest on 24 September 2021 mammalian uterus that are thought to mediate pregnancy-as- TIMPs) as well as distinct ones (e.g., secretory leukocyte sociated events primarily by regulating the activity of proteolytic protease inhibitor, SLPI, and uterine plasmin/trypsin inhib- enzymes. In the present study, we examined the mitogenic po- tentials of two serine protease inhibitors, namely secretory leu- itor, UPTI) [4, 8, 9]. Since embryos from all species, re- kocyte protease inhibitor (SLPI) and uterine plasmin/trypsin in- gardless of placentation type, exhibit invasive properties hibitor (UPTI) in primary cultures of glandular epithelial (GE) when placed into ectopic sites [10], the limiting of blasto- cells isolated from early pregnant (Day 12) pig endometrium, cyst invasiveness, albeit to varying extents, is most likely
    [Show full text]
  • Cardiac SARS‐Cov‐2 Infection Is Associated with Distinct Tran‐ Scriptomic Changes Within the Heart
    Cardiac SARS‐CoV‐2 infection is associated with distinct tran‐ scriptomic changes within the heart Diana Lindner, PhD*1,2, Hanna Bräuninger, MS*1,2, Bastian Stoffers, MS1,2, Antonia Fitzek, MD3, Kira Meißner3, Ganna Aleshcheva, PhD4, Michaela Schweizer, PhD5, Jessica Weimann, MS1, Björn Rotter, PhD9, Svenja Warnke, BSc1, Carolin Edler, MD3, Fabian Braun, MD8, Kevin Roedl, MD10, Katharina Scher‐ schel, PhD1,12,13, Felicitas Escher, MD4,6,7, Stefan Kluge, MD10, Tobias B. Huber, MD8, Benjamin Ondruschka, MD3, Heinz‐Peter‐Schultheiss, MD4, Paulus Kirchhof, MD1,2,11, Stefan Blankenberg, MD1,2, Klaus Püschel, MD3, Dirk Westermann, MD1,2 1 Department of Cardiology, University Heart and Vascular Center Hamburg, Germany. 2 DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck. 3 Institute of Legal Medicine, University Medical Center Hamburg‐Eppendorf, Germany. 4 Institute for Cardiac Diagnostics and Therapy, Berlin, Germany. 5 Department of Electron Microscopy, Center for Molecular Neurobiology, University Medical Center Hamburg‐Eppendorf, Germany. 6 Department of Cardiology, Charité‐Universitaetsmedizin, Berlin, Germany. 7 DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany. 8 III. Department of Medicine, University Medical Center Hamburg‐Eppendorf, Germany. 9 GenXPro GmbH, Frankfurter Innovationszentrum, Biotechnologie (FIZ), Frankfurt am Main, Germany. 10 Department of Intensive Care Medicine, University Medical Center Hamburg‐Eppendorf, Germany. 11 Institute of Cardiovascular Sciences,
    [Show full text]
  • LETTER Doi:10.1038/Nature14403
    LETTER doi:10.1038/nature14403 A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis Elvin Wagenblast1, Mar Soto1, Sara Gutie´rrez-A´ ngel1, Christina A. Hartl1, Annika L. Gable1, Ashley R. Maceli1, Nicolas Erard1,2, Alissa M. Williams1, Sun Y. Kim1, Steffen Dickopf1, J. Chuck Harrell3, Andrew D. Smith4, Charles M. Perou3, John E. Wilkinson5, Gregory J. Hannon1,2 & Simon R. V. Knott1,2 Cancer metastasis requires that primary tumour cells evolve the groups of clones contributed to lymph node and blood-borne meta- capacity to intravasate into the lymphatic system or vasculature, stases. Significant overlap existed between abundant clones in the and extravasate into and colonize secondary sites1. Others have blood-borne metastases and CTCs (Fig. 1b and Extended Data Fig. 1g, demonstrated that individual cells within complex populations P , 0.001, hypergeometric test). However, no significant overlap show heterogeneity in their capacity to form secondary lesions2–5. was observed when comparing these sets to the prominent clones in Here we develop a polyclonal mouse model of breast tumour het- the lymph node (Fig. 1b and Extended Data Fig. 1h). Indeed, others erogeneity, and show that distinct clones within a mixed popu- have reported that 20–30% of patients with distant relapse are free of lation display specialization, for example, dominating the axillary lymph-node metastases10. Thus, clonal populations within the primary tumour, contributing to metastatic populations, or show- 4T1 cell line reproducibly contribute to different aspects of disease ing tropism for entering the lymphatic or vasculature systems. We progression. correlate these stable properties to distinct gene expression pro- We wished to understand the properties of these clones, which files.
    [Show full text]
  • Micro-Encapsulated Secretory Leukocyte Protease Inhibitor Decreases Cell-Mediated Immune Response in Autoimmune Orchitis
    Life Sciences 89 (2011) 100–106 Contents lists available at ScienceDirect Life Sciences journal homepage: www.elsevier.com/locate/lifescie Micro-encapsulated secretory leukocyte protease inhibitor decreases cell-mediated immune response in autoimmune orchitis Vanesa Anabella Guazzone a,1, Diego Guerrieri b,1, Patricia Jacobo a, Romina Julieta Glisoni c, Diego Chiappetta c, Livia Lustig a, H. Eduardo Chuluyan b,⁎ a Instituto de Investigaciones en Reproducción, Facultad de Medicina, Universidad de Buenos Aires, Argentina b Departamento de Farmacología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina c Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Argentina article info abstract Article history: Aims: We previously reported that recombinant human Secretory Leukocyte Protease Inhibitor (SLPI) inhibits Received 29 November 2010 mitogen-induced proliferation of human peripheral blood mononuclear cells. To determine the relevance of Accepted 3 May 2011 this effect in vivo, we investigated the immuno-regulatory role of SLPI in an experimental autoimmune orchitis (EAO) model. Keywords: Main methods: In order to increase SLPI half life, poly-ε-caprolactone microspheres containing SLPI were Autoimmune orchitis prepared and used for in vitro and in vivo experiments. Multifocal orchitis was induced in Sprague–Dawley Secretory leukocyte protease inhibitor adult rats by active immunization with testis homogenate and adjuvants. Microspheres containing SLPI (SLPI Drug delivery systems Immuno-modulation group) or vehicle (control group) were administered s.c. to rats during or after the immunization period. fi Delayed type hypersensitivity Key ndings: In vitro SLPI-release microspheres inhibited rat lymphocyte proliferation and retained trypsin inhibitory activity. A significant decrease in EAO incidence was observed in the SLPI group (37.5%) versus the control group (93%).
    [Show full text]
  • The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane
    The Phospholipid Scramblases 1 and 4 Are Cellular Receptors for the Secretory Leukocyte Protease Inhibitor and Interact with CD4 at the Plasma Membrane Be´ne´dicte Py1,2., Ste´phane Basmaciogullari1,2.,Je´roˆ me Bouchet1,2, Marion Zarka1,2, Ivan C. Moura3,4, Marc Benhamou3,4, Renato C. Monteiro3,4, Hakim Hocini5, Ricardo Madrid1,2, Serge Benichou1,2* 1 Institut Cochin, Universite´ Paris-Descartes, CNRS, UMR 8104, Paris, France, 2 INSERM, U567, Paris, France, 3 INSERM U699, Paris, France, 4 Universite´ Paris 7-Denis Diderot, site Bichat, Paris, France, 5 INSERM U743, Paris, France Abstract Secretory leukocyte protease inhibitor (SLPI) is secreted by epithelial cells in all the mucosal fluids such as saliva, cervical mucus, as well in the seminal liquid. At the physiological concentrations found in saliva, SLPI has a specific antiviral activity against HIV-1 that is related to the perturbation of the virus entry process at a stage posterior to the interaction of the viral surface glycoprotein with the CD4 receptor. Here, we confirm that recombinant SLPI is able to inhibit HIV-1 infection of primary T lymphocytes, and show that SLPI can also inhibit the transfer of HIV-1 virions from primary monocyte-derived dendritic cells to autologous T lymphocytes. At the molecular level, we show that SLPI is a ligand for the phospholipid scramblase 1 (PLSCR1) and PLSCR4, membrane proteins that are involved in the regulation of the movements of phospholipids between the inner and outer leaflets of the plasma membrane. Interestingly, we reveal that PLSCR1 and PLSCR4 also interact directly with the CD4 receptor at the cell surface of T lymphocytes.
    [Show full text]
  • Comparative Transcriptome Analyses Reveal Genes Associated with SARS-Cov-2 Infection of Human Lung Epithelial Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.24.169268; this version posted June 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells Darshan S. Chandrashekar1, *, Upender Manne1,2,#, Sooryanarayana Varambally1,2,3,#* 1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 2O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 3Informatics Institute, University of Alabama at Birmingham, Birmingham, AL *Correspondence to: Sooryanarayana Varambally, Ph.D., Molecular and Cellular Pathology, Department of Pathology, Wallace Tumor Institute, 4th floor, 20B, University of Alabama at Birmingham, Birmingham, AL 35233, USA Phone: (205) 996-1654 Email: [email protected] And Darshan S. Chandrashekar Ph.D., Department of Pathology, University of Alabama at Birmingham, Birmingham, AL Email: [email protected] # Share Senior Authorship (UM Email: [email protected]) Running Title: SARS-CoV-2 gene signature in infected lung epithelial cells Disclosure of Potential Conflicts of Interest: No potential conflicts of interest were disclosed. Page | 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.24.169268; this version posted June 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract: Understanding the molecular mechanism of SARS-CoV-2 infection (the cause of COVID-19) is a scientific priority for 2020. Various research groups are working toward development of vaccines and drugs, and many have published genomic and transcriptomic data related to this viral infection.
    [Show full text]
  • SLPI Inhibits ATP-Mediated Maturation of IL-1Β in Human Monocytic Leukocytes: a Novel Function of an Old Player
    ORIGINAL RESEARCH published: 04 April 2019 doi: 10.3389/fimmu.2019.00664 SLPI Inhibits ATP-Mediated Maturation of IL-1β in Human Monocytic Leukocytes: A Novel Function of an Old Player Edited by: Anna Zakrzewicz 1†, Katrin Richter 1, Dariusz Zakrzewicz 2, Kathrin Siebers 1, Heiko Mühl, 1 1 1 3,4,5 Goethe-Universität Frankfurt am Jelena Damm , Alisa Agné , Andreas Hecker , J. Michael McIntosh , 6 7 8 9 Main, Germany Walee Chamulitrat , Gabriela Krasteva-Christ , Ivan Manzini , Ritva Tikkanen , Winfried Padberg 1, Sabina Janciauskiene 10 and Veronika Grau 1* Reviewed by: Francesco Di Virgilio, 1 Laboratory of Experimental Surgery, Department of General and Thoracic Surgery, German Center for Lung Research, University of Ferrara, Italy Justus-Liebig-University Giessen, Giessen, Germany, 2 German Center for Lung Research, Faculty of Medicine, Institute of Katrina Gee, Biochemistry, Justus-Liebig-University Giessen, Giessen, Germany, 3 Department of Biology, University of Utah, Salt Lake Queen’s University, Canada City, UT, United States, 4 George E. Wahlen Veterans Affairs, Medical Center, Salt Lake City, UT, United States, 5 Department *Correspondence: of Psychiatry, University of Utah, Salt Lake City, UT, United States, 6 Department of Internal Medicine IV, University Heidelberg Veronika Grau Hospital, Heidelberg, Germany, 7 Faculty of Medicine, Institute of Anatomy and Cell Biology, Saarland University, Homburg, Veronika.Grau@ Germany, 8 Department of Animal Physiology and Molecular Biomedicine, Justus-Liebig-University Giessen, Giessen, chiru.med.uni-giessen.de Germany, 9 Faculty of Medicine, Institute of Biochemistry, Justus-Liebig-University, Giessen, Germany, 10 Department of Respiratory Medicine, German Center for Lung Research, Hannover Medical School, Hannover, Germany †Present Address: Anna Zakrzewicz, Faculty of Medicine, Institute of Interleukin-1β (IL-1β) is a potent, pro-inflammatory cytokine of the innate immune Biochemistry, Justus-Liebig-University system that plays an essential role in host defense against infection.
    [Show full text]
  • Human Antimicrobial Peptides and Proteins
    Pharmaceuticals 2014, 7, 545-594; doi:10.3390/ph7050545 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review Human Antimicrobial Peptides and Proteins Guangshun Wang Department of Pathology and Microbiology, College of Medicine, University of Nebraska Medical Center, 986495 Nebraska Medical Center, Omaha, NE 68198-6495, USA; E-Mail: [email protected]; Tel.: +402-559-4176; Fax: +402-559-4077. Received: 17 January 2014; in revised form: 15 April 2014 / Accepted: 29 April 2014 / Published: 13 May 2014 Abstract: As the key components of innate immunity, human host defense antimicrobial peptides and proteins (AMPs) play a critical role in warding off invading microbial pathogens. In addition, AMPs can possess other biological functions such as apoptosis, wound healing, and immune modulation. This article provides an overview on the identification, activity, 3D structure, and mechanism of action of human AMPs selected from the antimicrobial peptide database. Over 100 such peptides have been identified from a variety of tissues and epithelial surfaces, including skin, eyes, ears, mouths, gut, immune, nervous and urinary systems. These peptides vary from 10 to 150 amino acids with a net charge between −3 and +20 and a hydrophobic content below 60%. The sequence diversity enables human AMPs to adopt various 3D structures and to attack pathogens by different mechanisms. While α-defensin HD-6 can self-assemble on the bacterial surface into nanonets to entangle bacteria, both HNP-1 and β-defensin hBD-3 are able to block cell wall biosynthesis by binding to lipid II. Lysozyme is well-characterized to cleave bacterial cell wall polysaccharides but can also kill bacteria by a non-catalytic mechanism.
    [Show full text]